These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12538635)

  • 21. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue of pituitary function in a mouse model of isolated growth hormone deficiency type II by RNA interference.
    Shariat N; Ryther RC; Phillips JA; Robinson IC; Patton JG
    Endocrinology; 2008 Feb; 149(2):580-6. PubMed ID: 18006625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II.
    Ryther RC; McGuinness LM; Phillips JA; Moseley CT; Magoulas CB; Robinson IC; Patton JG
    Hum Genet; 2003 Jul; 113(2):140-8. PubMed ID: 12720086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice site mutations in GH1 detected in previously (Genetically) undiagnosed families with congenital isolated growth hormone deficiency type II.
    Kempers MJ; van der Crabben SN; de Vroede M; Alfen-van der Velden J; Netea-Maier RT; Duim RA; Otten BJ; Losekoot M; Wit JM
    Horm Res Paediatr; 2013; 80(6):390-6. PubMed ID: 24280736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency.
    Vivenza D; Guazzarotti L; Godi M; Frasca D; di Natale B; Momigliano-Richiardi P; Bona G; Giordano M
    J Clin Endocrinol Metab; 2006 Mar; 91(3):980-6. PubMed ID: 16368751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis.
    Salemi S; Yousefi S; Lochmatter D; Eblé A; Deladoëy J; Robinson IC; Simon HU; Mullis PE
    Endocrinology; 2007 Jan; 148(1):45-53. PubMed ID: 17038549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.
    Wells SE; Flavell DM; Bisset GW; Houston PA; Christian H; Fairhall KM; Robinson IC
    J Physiol; 2003 Aug; 551(Pt 1):323-36. PubMed ID: 12813157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different degrees of somatotroph ablation compromise pituitary growth hormone cell network structure and other pituitary endocrine cell types.
    Waite E; Lafont C; Carmignac D; Chauvet N; Coutry N; Christian H; Robinson I; Mollard P; Le Tissier P
    Endocrinology; 2010 Jan; 151(1):234-43. PubMed ID: 19887571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged retention after aggregation into secretory granules of human R183H-growth hormone (GH), a mutant that causes autosomal dominant GH deficiency type II.
    Zhu YL; Conway-Campbell B; Waters MJ; Dannies PS
    Endocrinology; 2002 Nov; 143(11):4243-8. PubMed ID: 12399418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of isolated autosomal dominant GH deficiency (IGHD II): impact of the P89L GH mutation on clinical follow-up and GH secretion.
    Salemi S; Yousefi S; Baltensperger K; Robinson IC; Eblé A; Simon D; Czernichow P; Binder G; Sonnet E; Mullis PE
    Eur J Endocrinol; 2005 Dec; 153(6):791-802. PubMed ID: 16322384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice.
    Tang K; Bartke A; Gardiner CS; Wagner TE; Yun JS
    Endocrinology; 1993 Jun; 132(6):2518-24. PubMed ID: 8504754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated growth hormone deficiency: analysis of the growth hormone (GH)-releasing hormone gene and the GH gene cluster.
    Mullis P; Patel M; Brickell PM; Brook CG
    J Clin Endocrinol Metab; 1990 Jan; 70(1):187-91. PubMed ID: 1967179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of growth hormone deficiency.
    Mullis PE
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):17-36. PubMed ID: 17336732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic preprosomatostatin messenger ribonucleic acid expression in mice transgenic for excess or deficient endogenous growth hormone.
    Hurley DL; Phelps CJ
    Endocrinology; 1992 Apr; 130(4):1809-15. PubMed ID: 1347738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutations in the GH gene (GH1) uncover putative splicing regulatory elements.
    Babu D; Mellone S; Fusco I; Petri A; Walker GE; Bellone S; Prodam F; Momigliano-Richiardi P; Bona G; Giordano M
    Endocrinology; 2014 May; 155(5):1786-92. PubMed ID: 24635352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of GH-releasing hormone (GHRH) mutations in selected patients with isolated GH deficiency.
    França MM; Jorge AA; Alatzoglou KS; Carvalho LR; Mendonca BB; Audi L; Carrascosa A; Dattani MT; Arnhold IJ
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1457-60. PubMed ID: 21715545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of gonadotropin deficiency in a patient with type II autosomal dominant GH deficiency.
    Turton JP; Buchanan CR; Robinson IC; Aylwin SJ; Dattani MT
    Eur J Endocrinol; 2006 Dec; 155(6):793-9. PubMed ID: 17132747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural analysis of human growth hormone with respect to the dominant expression of growth hormone (GH) mutations in isolated GH deficiency type II.
    Iliev DI; Wittekindt NE; Ranke MB; Binder G
    Endocrinology; 2005 Mar; 146(3):1411-7. PubMed ID: 15591149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms responsible for dominant expression of human growth hormone gene mutations.
    Binder G; Brown M; Parks JS
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4047-50. PubMed ID: 8923859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.